Kewaunee Scientific Q1 sales up 47%; EPS $1.04; backlog $205M; expects FY EBITDA increase

KEWAUNEE SCIENTIFIC CORP /DE/

2026-Q1 EPS reported $1.04 revenue$71,104,000

Sales $71.1M (+46.9% YoY); diluted EPS $1.04 vs $0.74; net earnings $3.09M.
Domestic sales $54.4M (+53%) driven by Nu Aire acquisition and improved productivity.
Backlog $205M near historical highs; CEO warns of uneven quarterly performance ahead.
Expects better unadjusted EBITDA in FY2026 vs FY2025 despite strategic investments.
Corporate segment pre-tax loss $3.1M due to SOX 404(b) compliance and growth investments.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.